E12V0004 Chicken Vascular Endothelial Growth Factor Receptor 2 ELISA kit
Chicken Vascular Endothelial Growth Factor Receptor 2 ELISA kit is suitable for the detection of samples from chicken species. Vascular Endothelial Growth Factor Receptor 2 also be called VEGF Receptor 2, Fetal liver kinase 1, FLK-1, FLK1, KDR, Kinase insert domain receptor (a type III receptor tyrosine kinase), Kinase insert domain receptor, KRD1, Ly73, Protein tyrosine kinase receptor FLK1, VEGFR2.
Product Information | |
Cat. No. | E12V0004 |
Product Name | Chicken Vascular Endothelial Growth Factor Receptor 2 ELISA kit |
Species | Chicken |
Product Size | 48 Tests / 96 Tests |
Concentration | 0.5-10ng/ml |
Sensitivity | 0.1 ng/mL |
Principal | Competitive ELISA |
Sample Volume | 100 ul |
Sample Type | Serum, plasma, cell culture supernatants, body fluid and tissue homogenate |
Assay Time | 90 minutes |
Platform | Microplate Reader |
Conjugate | HRP |
Detection Method | Colorimetric |
Storage | 2-8°C |
Kit Components | ||
MATERIALS | SPECIFICATION | QUANTITY |
MICROTITER PLATE | 96 wells | stripwell |
ENZYME CONJUGATE | 6.0 mL | 1 vial |
STANDARD A (0.5mL) | 0 ng/mL | 1 vial |
STANDARD B (0.5mL) | 1.0 ng/mL | 1 vial |
STANDARD C (0.5mL) | 0.5 ng/mL | 1 vial |
STANDARD D (0.5mL) | 2.5 ng/mL | 1 vial |
STANDARD E (0.5mL) | 5.0 ng/mL | 1 vial |
STANDARD F (0.5mL) | 10 ng/mL | 1 vial |
SUBSTRATE A | 6 mL | 1 vial |
SUBSTRATE B | 6 mL | 1 vial |
STOP SOLUTION | 6 mL | 1 vial |
WASH SOLUTION (100 x) | 10 mL | 1 vial |
BALANCE SOLUTION | 3 mL | 1 vial |
Principle of the Assay |
VEGFR2 ELISA kit applies the competitive enzyme immunoassay technique utilizing an anti-VEGFR2 antibody and an VEGFR2-HRP conjugate. The assay sample and buffer are incubated together with VEGFR2-HRP conjugate in pre-coated plate for one hour. After the incubation period, the wells are decanted and washed five times. The wells are then incubated with a substrate for HRP enzyme. The product of the enzyme-substrate reaction forms a blue colored complex. Finally, a stop solution is added to stop the reaction, which will then turn the solution yellow. The intensity of color is measured spectrophotometrically at 450nm in a microplate reader. The intensity of the color is inversely proportional to the VEGFR2 concentration since VEGFR2 from samples and VEGFR2-HRP conjugate compete for the anti-VEGFR2 antibody binding site. Since the number of sites is limited, as more sites are occupied by VEGFR2 from the sample, fewer sites are left to bind VEGFR2-HRP conjugate. A standard curve is plotted relating the intensity of the color (O.D.) to the concentration of standards. The VEGFR2 concentration in each sample is interpolated from this standard curve. |
Coefficient of Variance | Intra Variation% ＜10% | |
Inter Variation% ＜12% | ||
Recovery | 88-116.69% | |
Linearity | Diluent Ratio | Range % |
1:2 | 95-117 | |
1:4 | 91-107 | |
1:8 | 89 -104 | |
Specificity/Cross-reactivity | No significant cross-reactivity or interference between VEGFR2 and analogues was observed. | |
E12V0004 has been referenced in the below publications:
The Effect of the Compound Traditional Chinese Medicine on Endothelium Derived Multiplication Factor in Lung of Broilers with Ascites Syndrome.
Related Bluegene Biotech Products
BlueGene Biotech News
